Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB26FX4LS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $131,927
Award facts
- Contract value 100% obligated
- $131,927.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $131,927.29 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2-pen/ml format on November 6, 2025, with an ultimate completion date of November 7, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables global pharmaceutical support for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated significant capability in federal medical procurement through competitive awards with the DLA Medical Supply Chain. The company supplies an extensive portfolio of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. Cosentyx is a biologic immunosuppressant used for autoimmune conditions, supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through flexible contract vehicles designed to meet dynamic military medical supply requirements.
Quick answers
Who was awarded contract SPE2DB26FX4LS?
SPE2DB26FX4LS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FX4LS worth?
The government has obligated $131,927 on SPE2DB26FX4LS.
Is contract SPE2DB26FX4LS an order under another contract?
Yes. SPE2DB26FX4LS is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX4LS competed?
The extent of competition for SPE2DB26FX4LS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award